CXCL16 and neoplasm: The activation of NKT cell enrichment depends on the bile duct conversion in a C-X-C motif chemokine ligand 16 (CXCL16) manner, so the aberrant microbiome translocation in the gut will diminish NKT cell accumulation, thus impeding anti-tumor effects [123].